Serum NGAL as a Predictor of Clinical and Endoscopic Activity of Inflammatory Bowel Disease

Assiut University80 enrolled

Overview

Ulcerative colitis (UC) and Crohns disease (CD) represent the two major forms of inflammatory bowel disease (IBD), characterized by epithelial cell damage and prominent mucosal infiltration by inflammatory cells including granulocytes, macrophages, lymphocytes, and plasma cells.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Inflammatory Bowel Diseases

Eligibility

Sex: ALLMin age: 15 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: IBD patients diagnosed by endoscopy. Male and female gender. Disease activity proven clinically and endoscopy . Assiut university hospital patients Exclusion Criteria: * Patients who refuse to contribute in this study Pregnancy and breast feeding Cancer patients Renal pathology Diabetes Mellitus Cardiovascular patients Pancreatitis COPD patients

Outcomes

Primary Outcomes

test the sensitivity and specificity of using NGAL in diagnosis of IBD

Time frame: One year

Central Contacts

Mohamed Alsadek Ma Ghozaly, Master

CONTACT

01150993206 alsadekmohamed215@gmail.com

Hossam Ma Abd Alwahab

CONTACT

01146539976

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.